These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 17606566)

  • 1. Cost-effectiveness of alternative strategies for tuberculosis screening before kindergarten entry.
    Flaherman VJ; Porco TC; Marseille E; Royce SE
    Pediatrics; 2007 Jul; 120(1):90-9. PubMed ID: 17606566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis of targeted and sequential screening strategies for latent tuberculosis.
    Mancuso JD; Niebuhr DW; Frick KD; Keep LW; Anderson KM
    Int J Tuberc Lung Dis; 2011 Sep; 15(9):1223-30, i. PubMed ID: 21943850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost-effectiveness of preventing tuberculosis in physicians using tuberculin skin testing or a hypothetical vaccine.
    Nettleman MD; Geerdes H; Roy MC
    Arch Intern Med; 1997 May; 157(10):1121-7. PubMed ID: 9164378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers.
    de Perio MA; Tsevat J; Roselle GA; Kralovic SM; Eckman MH
    Arch Intern Med; 2009 Jan; 169(2):179-87. PubMed ID: 19171815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a school-based tuberculosis-screening program and associate investigation targeting recently immigrated children in a low-burden country.
    Brassard P; Steensma C; Cadieux L; Lands LC
    Pediatrics; 2006 Feb; 117(2):e148-56. PubMed ID: 16452324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A risk/cost analysis of alternative screening intervals for occupational tuberculosis infection.
    Nicas M
    Am Ind Hyg Assoc J; 1998 Feb; 59(2):104-12. PubMed ID: 9487664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculosis screening in internationally adopted children: the need for initial and repeat testing.
    Trehan I; Meinzen-Derr JK; Jamison L; Staat MA
    Pediatrics; 2008 Jul; 122(1):e7-14. PubMed ID: 18595977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis of screening adolescent males for Chlamydia on admission to detention.
    Blake DR; Gaydos CA; Quinn TC
    Sex Transm Dis; 2004 Feb; 31(2):85-95. PubMed ID: 14743071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for celiac disease in asymptomatic children with Down syndrome: cost-effectiveness of preventing lymphoma.
    Swigonski NL; Kuhlenschmidt HL; Bull MJ; Corkins MR; Downs SM
    Pediatrics; 2006 Aug; 118(2):594-602. PubMed ID: 16882812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic evaluation of tandem mass spectrometry screening in California.
    Feuchtbaum L; Cunningham G
    Pediatrics; 2006 May; 117(5 Pt 2):S280-6. PubMed ID: 16735254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A university hospital's 10-year experience with tuberculin testing: value of the 2-step tuberculin skin test.
    Choudhary M; Ramirez L; Long R; Simmons KB; Blair DC; Forbes BA; Same K; Ploutz-Snyder R; Rose FB
    Am J Infect Control; 2006 Aug; 34(6):358-61. PubMed ID: 16877104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of a new interferon-based blood assay, QuantiFERON-TB Gold, in screening tuberculosis contacts.
    Marra F; Marra CA; Sadatsafavi M; Morán-Mendoza O; Cook V; Elwood RK; Morshed M; Brunham RC; Fitzgerald JM
    Int J Tuberc Lung Dis; 2008 Dec; 12(12):1414-24. PubMed ID: 19017451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cost-effectiveness analysis of QuantiFERON-TB 2nd generation used for detection of tuberculosis infection in contact investigations].
    Mori T; Harada N
    Kekkaku; 2005 Nov; 80(11):675-86. PubMed ID: 16363672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis screening for long-term care: a cost-effectiveness analysis.
    Verma G; Chuck AW; Jacobs P
    Int J Tuberc Lung Dis; 2013 Sep; 17(9):1170-7. PubMed ID: 23928166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. School based screening for tuberculosis infection in Norway: comparison of positive tuberculin skin test with interferon-gamma release assay.
    Winje BA; Oftung F; Korsvold GE; Mannsåker T; Ly IN; Harstad I; Dyrhol-Riise AM; Heldal E
    BMC Infect Dis; 2008 Oct; 8():140. PubMed ID: 18928541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latent tuberculosis infection in children: a call for revised treatment guidelines.
    Finnell SM; Christenson JC; Downs SM
    Pediatrics; 2009 Mar; 123(3):816-22. PubMed ID: 19255008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of directly observed chemoprophylaxis of tuberculosis among drug users at high risk for tuberculosis.
    Gourevitch MN; Alcabes P; Wasserman WC; Arno PS
    Int J Tuberc Lung Dis; 1998 Jul; 2(7):531-40. PubMed ID: 9661818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. School-based screening for tuberculous infection. A cost-benefit analysis.
    Mohle-Boetani JC; Miller B; Halpern M; Trivedi A; Lessler J; Solomon SL; Fenstersheib M
    JAMA; 1995 Aug 23-30; 274(8):613-9. PubMed ID: 7637141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling the cost-effectiveness of strategies to prevent tuberculosis in child contacts in a high-burden setting.
    Mandalakas AM; Hesseling AC; Gie RP; Schaaf HS; Marais BJ; Sinanovic E
    Thorax; 2013 Mar; 68(3):247-55. PubMed ID: 22717944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An alternative to 'two-step' tuberculin skin testing for Southeast Asian refugees.
    Wenzel M
    Nurse Pract; 1991 Sep; 16(9):25-8. PubMed ID: 1945074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.